Skip to main content
OPKO Health Inc. logo

OPKO Health Inc. — Investor Relations & Filings

Ticker · OPK ISIN · US68375N1037 LEI · 529900A4S2D4OGOJLL02 TA Human health and social work activities
Open in API
Filings indexed 3,780 across all filing types
Latest filing 2024-03-30 Report Publication Anno…
Country US United States of America
Listing TA OPK

About OPKO Health Inc.

https://www.opko.com

OPKO Health, Inc. is a fully-integrated healthcare company operating in both pharmaceuticals and diagnostics. Its pharmaceutical division develops and commercializes novel therapies for serious diseases. Key marketed products include NGENLA™, a long-acting treatment for pediatric growth hormone deficiency partnered with Pfizer, and RAYALDEE®. The company's research focuses on advancing multispecific therapies for cancers and infectious diseases. Through its subsidiary, BioReference Laboratories, OPKO operates one of the largest full-service clinical reference laboratories in the U.S., providing comprehensive diagnostic testing services to millions of patients annually.

Recent filings

Filing Released Lang Actions
Form 4- CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Alice Lin-Tsing Yu, M.D., Ph.D.
Report Publication Announcement Classification · 98% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). The content explicitly states, 'Attached hereto is a report on *Interested party transaction* *20240330Form4Yu_isa.pdf*'. This structure—a brief announcement stating that a specific report (in this case, related to an interested party transaction) is attached or published—fits the definition of a Report Publication Announcement (RPA). It is not the full transaction report itself, but the notification of its release. The document length is very short (1770 chars), reinforcing the RPA classification over a comprehensive report type like 10-K or IR.
2024-03-30 English
Form 4- CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Richard C. Pfenniger, Jr.
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "FORM 4" and the title "STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934". Form 4 is the standard SEC filing used by corporate insiders (directors, officers, and 10% owners) to report changes in their beneficial ownership of the company's securities. This directly corresponds to the definition of Director's Dealing (insider trades). The filing type code for Director's Dealing is DIRS.
2024-03-30 English
Form 4- CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Richard C. Pfenniger, Jr.
Report Publication Announcement Classification · 95% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). The content explicitly states it is a report on an 'Interested party transaction' and directs the reader to an attached PDF file ('20240330Form4Pfenniger_isa.pdf'). Since the document itself is short and serves primarily to announce the availability of a specific report (an interested party transaction disclosure, which often falls under related party disclosures or specific regulatory filings), it fits the description of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the specific nature of the attached report (Interested Party Transaction), and the fact that there is no specific code for 'Interested Party Transaction Report', we must check the closest fits. 'LTR' (Legal Proceedings Report) is incorrect. 'DIRS' (Director's Dealing) is incorrect. 'DEF 14A' (Remuneration) is incorrect. Since this is a mandatory regulatory disclosure announcing the publication of a specific report, and it is not a comprehensive report itself (like 10-K or IR), RPA or RNS are the best candidates. RPA is for announcing the publication of reports. Given the context of mandatory regulatory disclosure via MAGNA, RNS (Regulatory Filings - general fallback) is a very strong candidate, but RPA specifically covers the announcement of report publication. Since the document is very short and points to an attachment, RPA is slightly more precise than the general RNS fallback, although RNS would also be acceptable if RPA didn't exist. I will select RPA as it announces the publication of a specific report.
2024-03-30 English
Form 4- CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- John A.Paganelli
Director's Dealing Classification · 100% confidence The document explicitly begins with 'FORM 4' and 'UNITED STATES SECURITIES AND EXCHANGE COMMISSION' and is titled 'STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES'. Form 4 is the standard SEC filing used by corporate insiders (directors, officers, or 10% owners) to report transactions in the issuer's securities. This directly corresponds to the definition of Director's Dealing (insider trades).
2024-03-30 English
Form 4- CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- John A.Paganelli
Report Publication Announcement Classification · 98% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). The content explicitly states: 'Attached hereto is a report on *Interested party transaction* *20240330Form4Paganelli_isa.pdf*'. This structure—a brief regulatory filing announcing that a specific report (in this case, related to an interested party transaction, which often falls under insider dealings or related-party disclosures) is attached or published—fits the definition of a Report Publication Announcement (RPA). It is not the full transaction report itself, but the announcement of its publication. Given the context of interested party transactions and the short nature of this announcement (1777 chars), RPA is the most appropriate classification, as it signals the release of another document.
2024-03-30 English
Form 4- CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Roger J. Medel, M.D.
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "FORM 4" and "STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934". Form 4 filings are mandatory disclosures for insiders (directors, officers, or 10% owners) reporting transactions in the company's securities. This directly corresponds to the definition of Director's Dealing (DIRS) or insider trade reporting, which is covered by the 'DIRS' code in the provided schema, although the schema definition for DIRS is 'Director's Dealing (Code: DIRS): Report of personal share transactions by company directors and executives (insider trades)'. The presence of 'Roger J. Medel, M.D.' listed as 'X Director' confirms this classification.
2024-03-30 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.